Pain ROADMAP A Mobile Platform to support activity pacing for - - PowerPoint PPT Presentation

▶
pain roadmap
SMART_READER_LITE
LIVE PREVIEW

Pain ROADMAP A Mobile Platform to support activity pacing for - - PowerPoint PPT Presentation

Feb 15, 2024 24 likes •289 views

Pain ROADMAP A Mobile Platform to support activity pacing for chronic pain Dr David Ireland Australias National Science Agency Chronic Pain: Persisting more than 3 months Effects 20% of Australians The Cost of pain in Australia: A

slide-1
SLIDE 1

Australia’s National Science Agency

Pain ROADMAP

A Mobile Platform to support activity pacing for chronic pain

Dr David Ireland

slide-2
SLIDE 2
  • Effects 20% of Australians

Chronic Pain: Persisting more than 3 months

The Cost of pain in Australia: A Painful Reality, Deloitte Access Economics, March 2019

slide-3
SLIDE 3
  • Effects 20% of Australians
  • Third most costly condition in Australia

Chronic Pain: Persisting more than 3 months

The Cost of pain in Australia: A Painful Reality, Deloitte Access Economics, March 2019

slide-4
SLIDE 4
  • Effects 20% of Australians
  • Third most costly condition in Australia
  • Social isolation, fatigue and sleep disturbances

Chronic Pain: Persisting more than 3 months

The Cost of pain in Australia: A Painful Reality, Deloitte Access Economics, March 2019

slide-5
SLIDE 5
  • Effects 20% of Australians
  • Third most costly condition in Australia
  • Social isolation, fatigue and sleep disturbances
  • More deaths from prescription opioids than illicit drugs

Chronic Pain: Persisting more than 3 months

The Cost of pain in Australia: A Painful Reality, Deloitte Access Economics, March 2019

slide-6
SLIDE 6
  • Effects 20% of Australians
  • Third most costly condition in Australia
  • Social isolation, fatigue and sleep disturbances
  • More deaths from subscription opioids than illicit drugs
  • Desire but fear of tampering off medications

Chronic Pain: Persisting more than 3 months

The Cost of pain in Australia: A Painful Reality, Deloitte Access Economics, March 2019

slide-7
SLIDE 7
  • Effects 20% of Australians
  • Third most costly condition in Australia
  • Social isolation, fatigue and sleep disturbances
  • More deaths from subscription opioids than illicit drugs
  • Desire but fear of tampering off medications
  • Quality of life does improve when managed

Chronic Pain: Persisting more than 3 months

The Cost of pain in Australia: A Painful Reality, Deloitte Access Economics, March 2019

slide-8
SLIDE 8
  • Reschedule daily activities so not to aggravate pain
  • Doing too much (or too little) is a significant factor
  • But what activities are the problem?
  • How can we capture this information?

Activity Pacing

slide-9
SLIDE 9
  • Rediscover
  • Occupation &
  • Achieve &
  • Develop through a
  • Monitoring
  • App for
  • Pain

Pain ROADMAP

slide-10
SLIDE 10

Mobile Application

slide-11
SLIDE 11

Mobile Application

  • Activity
  • Time
  • Medications
  • Pain
  • Over did it?
  • What about privacy?
slide-12
SLIDE 12

Mobile Application

slide-13
SLIDE 13
  • Actigraph accelerometer placed around the wait
  • Asked to wear except for showering & swimming
  • Measures gross movements
  • Independent data stream

Wearable

slide-14
SLIDE 14
  • Generates daily graphs to identify activity periods
  • Contains no identifiable data
  • Daily and weekly summary of:

–Opioids & PRN medication –Pain intensity & variation –% Time rest, productive & leisure activities

Clinical Portal

slide-15
SLIDE 15
  • Participants were asked to set goals
  • 3 x home monitoring periods
  • 3 x clinic visits for data review & rescheduling advice
  • 2 x tele-consultations

Three Month Protocol

slide-16
SLIDE 16
  • Recruited 20 individuals with chronic pain
  • Individuals has pain impacting gross motor
  • Previous struggled with centre based treatment
  • 4 dropouts to personal circumstances
  • Good compliance: only 4 repeats

Pilot Summary

slide-17
SLIDE 17

Data from 1st Monitoring Session

slide-18
SLIDE 18
  • Observed over activity periods decreased from

2.5 to 0.25 (p < 0.001)

After Pain ROADMAP Intervention

slide-19
SLIDE 19
  • Observed over activity periods decreased from

2.5 to 0.25 (p < 0.001)

  • Pain levels stabilised (p < 0.001)

After Pain ROADMAP Intervention

slide-20
SLIDE 20
  • Observed over activity periods decreased from

2.5 to 0.25 (p < 0.001)

  • Pain levels stabilised (p < 0.001)
  • Extra 49 minutes of productive time on average

After Pain ROADMAP Intervention

slide-21
SLIDE 21
  • Observed over activity periods decreased from

2.5 to 0.25 (p < 0.001)

  • Pain levels stabilised (p < 0.001)
  • Extra 49 minutes of productive time on average
  • 5 (of 7) individuals ceased PRN medication

After Pain ROADMAP Intervention

slide-22
SLIDE 22
  • Observed over activity periods decreased from

2.5 to 0.25 (p < 0.001)

  • Pain levels stabilised (p < 0.001)
  • Extra 49 minutes of productive time on average
  • 5 (of 7) individuals ceased PRN medication
  • Decreased opioid intake by 20% on average

After Pain ROADMAP Intervention

slide-23
SLIDE 23
  • Observed over activity periods decreased from

2.5 to 0.25 (p < 0.001)

  • Pain levels stabilised (p < 0.001)
  • Extra 49 minutes of productive time on average
  • 5 (of 7) individuals ceased PRN medication
  • Decreased opioid intake by 20% on average
  • 2 individuals went back to work fulfilling a planned goal

After Pain ROADMAP Intervention

slide-24
SLIDE 24
slide-25
SLIDE 25
  • Multi-site implementation
  • Paediatric version using gamification
  • 50% children with communication challenges have

undiagnosed pain

Current & Future Work

slide-26
SLIDE 26

Australia’s National Science Agency

Thank you

Come and visit us at the CSIRO booth # 35 Our researchers and scientists would love to share more with you about how their work is enabling digital health in Australia and around the world.